The increase in ECM synthesis by PSCs upon exposure to cancer cells is thought to be mediated by transforming growth factor beta 1 (TGFβ 1) and fibroblast growth factor 2 (FGF2) (Bachem et al., 2005). The gene discussed is FGF2; the disease is cancer.